The Rx Daily Dose

Here are the links for everything discussed in Episode 87. Times are also below so feel free to skip around and get to the updates that interest you.  (1:08) Approval of Hemgenix for Hemophilia B (4:45) Rebyota approved for recurrence of CDiff infection (9:39) New approval for AML with IDH1 mutation - Rezlidhia CDC website for COVID information - get boosted!FDA monkeypox response websiteConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 86. Times are also below so feel free to skip around and get to the updates that interest you.  (1:17) FDA approves Tzield for Type 1 Diabetes (5:45) Rezvoglar approved as interchangeable biosimilar (6:32) New EUA for Kineret for COVID19 CDC website for COVID information - get boosted!FDA monkeypox response websiteConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 85. Times are also below so feel free to skip around and get to the updates that interest you.  (1:12) Warning about Xylazine being added into illicit drugs (3:39) Flu, COVID, RSV - "The Tripledemic"  PAXLOVID Patient Eligibility Screening Checklist Tool for PrescribersCDC website for COVID information - get boosted!FDA monkeypox response websiteConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 84. Times are also below so feel free to skip around and get to the updates that interest you.  1:05) Tecvayli approval for multiple myeloma (6:16) Imjudo approval for liver cancer (HCC) PAXLOVID Patient Eligibility Screening Checklist Tool for PrescribersCDC website for COVID information - get boosted!FDA monkeypox response websiteConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 83. Times are also below so feel free to skip around and get to the updates that interest you.  (1:11) FDA amends EUA for bivalent booster vaccines (8:23) FDA announces shortage of immediate release amphetamine salts PAXLOVID Patient Eligibility Screening Checklist Tool for PrescribersCDC website for COVID information - get boosted!FDA monkeypox response websiteConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 82. Times are also below so feel free to skip around and get to the updates that interest you.  (1:10) FDA adds new indication for Boostrix vaccine (6:44) FDA updated the authorized fact sheet for Evusheld PAXLOVID Patient Eligibility Screening Checklist Tool for PrescribersCDC website for COVID information - get boosted!FDA monkeypox response websiteConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 80. Times are also below so feel free to skip around and get to the updates that interest you.  (1:14) FDA issues warning related to OTC meds & social media challenges (4:20) FDA approval of Skysona for CALD (6:07) New indication for Retevmo (7:12) FDA approves Relyvrio for ALS PAXLOVID Patient Eligibility Screening Checklist Tool for PrescribersCDC website for COVID information - get boosted!FDA monkeypox response websiteConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 80. Times are also below so feel free to skip around and get to the updates that interest you.  (1:12) FDA approves Spevigo for GPP flares (3:03) Daxxify approved for treating glabellar lines PAXLOVID Patient Eligibility Screening Checklist Tool for PrescribersCDC website for COVID information - get boosted!FDA monkeypox response websiteConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 79. Times are also below so feel free to skip around and get to the updates that interest you.  (1:12) FDA authorizes updated booster doses for COVID19 (5:29) FDA approves Xenpozyme for ASMD PAXLOVID Patient Eligibility Screening Checklist Tool for PrescribersCDC website for COVID information - get boosted!FDA monkeypox response websiteConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 78. Times are also below so feel free to skip around and get to the updates that interest you.  (1:10) FDA final rule on OTC hearing aids (1:37) Moderna completes EUA for Omicron-targeting Booster (3:00) Pfizer and BioNTech submit EUA for omicron booster (4:03) FDA updates EUA for Novovax to include adolescents 12 to 17 years of age (5:05) New guidance for Paxlovid drug interactions (6:01) Single use vial of COMIRNATY approved (6:30) Omnipod 5 approved for children ages 2 and older (7:48) Approval of Auvelity for Major Depressive Disorder PAXLOVID Patient Eligibility Screening Checklist Tool for PrescribersCDC website for COVID information - get boosted!FDA monkeypox response websiteConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 77. Times are also below so feel free to skip around and get to the updates that interest you.  (1:10) FDA final rule on OTC hearing aids (4:35) Zynteglo gene therapy approved for beta thalassemia CDC website for COVID information - get boosted!FDA monkeypox response websiteConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 76. Times are also below so feel free to skip around and get to the updates that interest you.  (1:32) FDA issues EUA for JYNNEOS vaccine (5:05) FDA approves Enhertu for NSCLC w/ HER2 expression Other FDA approvals: (8:13) - Myfembree (8:43) - Nubeqa (9:08) - Calquence (9:36) - Xofluza CDC website for COVID information - get boosted!FDA monkeypox response websiteConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 75. Times are also below so feel free to skip around and get to the updates that interest you.  (1:13) Expanded EUA for Veklury (5:47) Spikevax vaccine approved by Moderna Other FDA approvals: (9:49) - Quviviq (11:13) - Enjaymo (12:34) - Felqsuvy (13:05) - Vabysmo CDC website for COVID information - get boosted!Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 74. Times are also below so feel free to skip around and get to the updates that interest you.  (1:12) New EUA issued for Pfizers Paxlovid, and new COVID antiviral treatment (7:25) FDA makes several update to Pfizers COVID vaccine EUA CDC website for COVID information - get boosted!Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 73. Times are also below so feel free to skip around and get to the drugs that interest you.  (1:17) New EUA issued for molnupiravir for treatment of COVID-19 (6:10) Apretude approved for pre-exposure prophylaxis/PrEP (9:33) New treatment approved for Myasthenia Gravis named Vyvgart (12:18) Tezspire approved for severe asthma CDC website for COVID information - get boosted!Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 72. Times are also below so feel free to skip around and get to the drugs that interest you.  (1:17) FDA approves Voxzogo for achondroplasia (3:58) Livtencity approved for treatment resistant CMV (7:36) New imaging product, Cytalux, approved to help identify ovarian cancer CDC website for COVID information - get boosted!Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 71. Times are also below so feel free to skip around and get to the drugs that interest you.  (1:18) Interchangeable MAB - Cyltezo approval (5:50) Seglentis approved for pain management (8:24) FDA authorizes EUA for Pfizer COVID19 vaccine Updated CDC recommendations for Pfizer COVID vaccine boostersConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 70. Times are also below so feel free to skip around and get to the drugs that interest you.  (1:16) Approval of Opzelura for atopic dermatitis (4:01) Qulipta approved for migraine prevention (5:54) New treatment for ALGS - Livmarli Updated CDC recommendations for Pfizer COVID vaccine boostersConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 69. Times are also below so feel free to skip around and get to the drugs that interest you.  (1:18) Approval of Exkivity for NSCLC (4:46) Tivdak approved for cervical cancer (7:41) New biosimilar for Luncetis approved called Byooviz (10:39) Pfizer/COVID vaccine EUA updates on booster shots Updated CDC recommendations for Pfizer COVID vaccine boostersConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 68. Times are also below so feel free to skip around and get to the drugs that interest you.  (1:18) Approval of Skytrofa a weekly human growth hormone (4:22) Invega Hayfera approved for schizophrenia (7:50) FDA issues new warning on JAK inhibitors Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 67. Times are also below so feel free to skip around and get to the drugs that interest you. And I apologize for the echo - need to find a better place to record in the new home :) (1:18) COVID19 vaccine approved as brand name Comirnaty (8:10) Amended EUA for COVID vaccines (10:20) Welireg approved for VHL Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 66. Times are also below so feel free to skip around and get to the drugs that interest you. And I apologize for the echo - need to find a better place to record in the new home :) (1:18) Approval of first interchangeable insulin called Semglee (6:13) Nexviazyme approved for Pompe disease (8:23) Approval of Rezurock for chronic graft vs host disease (CGVHD) Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 65. Times are also below so feel free to skip around and get to the drugs that interest you. (1:12) Approval of Rylaze for ALL and LBL (4:12) New EYA issued for Actemra for COVID19 CDC updates on COVID-19 & influenza reporting Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 64. Times are also below so feel free to skip around and get to the drugs that interest you. (1:23) New pediatric indication for Ultomiris for PNH (5:18) Pradaxa now approved for VTE in pediatric patients (9:34) Rx to OTC switch of Astepro CDC updates on COVID-19 & influenza reporting Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 63. Times are also below so feel free to skip around and get to the drugs that interest you. (1:18) New treatment for weight management - Wegovy (6:38) Lybalvi approved for schizophrenia and bipolar 1 (9:43) Controversial treatment for Alzheimers approved - Aduhelm CDC updates on COVID-19 & influenza reporting Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 62. Times are also below so feel free to skip around and get to the drugs that interest you. (1:17) Approval of Myfembree for uterine fibroids (5:05) Lumakras approved for NSCLC (8:25) Approval of Truseltiq for cholangiocarcinoma CDC updates on COVID-19 & influenza reporting Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 61. Times are also below so feel free to skip around and get to the drugs that interest you. (1:15) - Empaveli approved for PNH (4:35) - Approval of Rybrevant for NSCLC CDC updates on COVID-19 & influenza reporting Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 60. Times are also below so feel free to skip around and get to the drugs that interest you. (1:14) - Jemperli approved for advanced endometrial cancer (5:52) - Approval of Zynlonta for DLBCL CDC updates on COVID-19 & influenza reporting Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 59. Times are also below so feel free to skip around and get to the drugs that interest you. (1:15) -New contraceptive approved called Nextstellis (3:42) - Trodelvy added indications  CDC updates on COVID-19 & influenza reporting Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 58. Times are also below so feel free to skip around and get to the drugs that interest you. (1:27) - Qelbree approved for ADHD New indications for Tyvaso and Sarclisa CDC updates on COVID-19 & influenza reporting Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 57. Times are also below so feel free to skip around and get to the drugs that interest you. (0:47) Approval of Abecma for multiple myeloma CDC updates on COVID-19 & influenza reporting Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 56. Times are also below so feel free to skip around and get to the drugs that interest you. (1:12) Approval of Zegalogue for episodes of hypoglycemia (3:29) New indication approved for Arcalyst for pericarditis (5:20) Myrbetriq approved for neurogenic detrusor overactivity, NDO CDC updates on COVID-19 & influenza reporting Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 55. Times are also below so feel free to skip around and get to the drugs that interest you. (1:08) Approval on Ponvory for multiple sclerosis (5:55) Kimyrsa approval for SSSI including MRSA CDC updates on COVID-19 & influenza reporting Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 54. Times are also below so feel free to skip around and get to the drugs that interest you. (1:15) - Azstarys approved for ADHD (4:44) - Approval of Fotivda as new RCC treatment option (8:12) - Added indication for Yescarta in follicular lymphoma CDC updates on COVID-19 & influenza reporting Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 53. Times are also below so feel free to skip around and get to the drugs that interest you. (1:12) - EUA issued for Jansenn's COVID Vaccine (9:18) - Nulibry approved for Molybdenum Cofactor Deficiency Type A (11:55) - Approval of Pepaxto for multiple myeloma CDC updates on COVID-19 & influenza reporting Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 52. Times are also below so feel free to skip around and get to the drugs that interest you. (1:18) Ukoniq approved for certain types of NHL (5:18) New treatment for LDL cholesterol, Evkeeza approval (8:59) Cosela approval the pre-chemo treatment CDC updates on COVID-19 & influenza reporting Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 51. Times are also below so feel free to skip around and get to the drugs that interest you. (1:15) New treatment for heart failure approved, Verquvo (4:57) Cabometyx + Opdivo for advanced RCC (9:26) Approval of Tepmetko for NSCLC with MET alterations CDC updates on COVID-19 & influenza reportingConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 50. Times are also below so feel free to skip around and get to the drugs that interest you. (1:14) Gemtesa approval for OAB (4:01) New indication for Enhertu (7:15) New monthly injectable treatment for HIV - Cabenuva and Vocabria CDC updates on COVID-19 & influenza reportingConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 49. Times are also below so feel free to skip around and get to the drugs that interest you. (1:19) Margenza approval for HER2+ breast cancer (4:05) New oral treatment for prostate cancer going by Orgovyx (6:53) Moderna COVID-19 vaccine approval CDC updates on COVID-19 & influenza reportingConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 48 Orladeyo approval Danyelza approval FDA approval Pfizers/BioNTech COVID19 vaccine CDC updates on COVID-19 & influenza reportingConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 47, I'm also including times here so feel free to skip ahead to the topics that interest you. Vaccines should be approved next week, so keep an eye open for that podcast next week (1:25) Oxlumo approval for hyperoxaluria (4:24) Approval of Imcivree for genetic weight management (8:29) New EUAs for COVID 19 treatment  barcitinib and remdesivir casirivimab and imdevimab CDC updates on COVID-19 & influenza reportingConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 46, I'm also including times here so feel free to skip ahead to the topics that interest you. I hope everyone has a safe, happy, and socially distanced holiday! (1:08) Approval of Zokinvy for Hutchinson-Gilford progeria syndrome (4:37) New EUA authorized for banlamivimab for treatment of COVID19 CDC updates on COVID-19 & influenza reportingConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 45, I'm also including times here so feel free to skip ahead to the topics that interest you. (1:22) Approval of Veklury to treat COVID19 (8:38) Inmazeb approved for Ebola virus CDC updates on COVID-19 & influenza reportingConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 44, I'm also including times here so feel free to skip ahead to the topics that interest you. (1:20) Combination of Opdivo & Yervoy approved for mesothelioma (4:53) Nucala approved with new indication (8:08) New age group approved for Kalydeco (10:46) Xeljanz approved for pcJIA CDC updates on COVID-19 & influenza reportingConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 43, I'm also including times here so feel free to skip ahead to the topics that interest you. (1:18) Approval of Gavreto for RET-positive NSCLC (5:05) Qdolo approved for pain management in adults (6:44) New dosing guidelines and strengths for Trulicity CDC updates on COVID-19 & influenza reportingConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 42, I'm also including times here so feel free to skip ahead to the topics that interest you. (1:31) Enspryng approval for NMOSD treatment (5:32) Approval of Onureg for AML (8:06) Novel treatment for acne called Winlevi (8:59) Approval of Sogroya for GHD CDC updates on COVID-19 & influenza reportingConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 41, I'm also including times here so feel free to skip ahead to the topics that interest you. (1:18) Monjuvi approved for DLBCL (3:07) Approval of Lampit to treat Chagas disease (4:52) Evrysdi approved for spinal muscular atrophy (8:13) FDA approved Blenrep for multiple myeloma (10:09) Approval of Viltepso for Duchenne Muscular Dystrophy CDC updates on COVID-19 & influenza reportingConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 40, I'm also including times here so feel free to skip ahead to the topics that interest you. (1:27) Approval of Brextri for COPD maintenance (4:45) Xywav approved for cataplexy (7:42) New treatment for head lice - Xeglyze (10:19) Tecartus approval for MCL CDC updates on COVID-19 & influenza reportingConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 39, I'm also including times here so feel free to skip ahead to the topics that interest you. (1:15) - Approval of Rukobia for HIV treatment experienced patients (4:30) - Inqovi approved for treatment of MDS (7:10) - Approval of Upneeq for acquired blepharoptosis CDC updates on COVID-19 & influenza reportingConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 38, I'm also including times here so feel free to skip ahead to the topics that interest you. (1:26) - Approval of Crysvita for TIO (4:58) - Fintepla for Dravet syndrome (8:19) - New combination for HER-2 going by Phesgo (10:56) - Dojolvi approval  CDC updates on COVID-19 & influenza reportingConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Here are the links for everything discussed in Episode 37, I'm also including times here so feel free to skip ahead to the topics that interest you. (1:07) Approval of Uplizna for NMOSD (4:57) Zepzelca approval for mSCLC (7:18) New age indication for Tivicay (11:23) Ilaris approved for Still's Disease CDC updates on COVID-19 & influenza reporting Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★